Authors
Loading...
Review demonstrates near-inevitable viral recurrence in liver transplant recipients, suggesting combination interferon and ribavirin therapy can delay progressive graft disease.
Bizollon et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: